Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Cancer Immunotherapy and Biomarkers

82 та иш

  1. 30P Cemiplimab in treatment of metastatic and recurrent cervical cancer

    F.M. Djuraev, A.S. Abdujapparov

    МақолаCancer Immunotherapy and BiomarkersESMO Open20240 иқтибос
    ABI

  2. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

    Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

    Шарҳ мақолаCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 иқтибос
    ABI

  3. Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36

    Chun‐Yan Sang, Jia-Rong Liu, Yi-Dan Zheng +6

    МақолаCancer Immunotherapy and BiomarkersEuropean Journal of Pharmacology20250 иқтибос
    ABI

  4. Current trends on immunotherapy for oncology

    Neya Kavya Chander, A Prashannalakshmi, Phanish Chandra Ravi +4

    МақолаImmunotherapy and Immune ResponsesBioinformation20250 иқтибос
    ABI

  5. Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)

    Thabit Moath Omar, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +8

    МақолаCancer Research and TreatmentsExpert Review of Anticancer Therapy20250 иқтибос
    ABI

  6. DECIPHERING THE IMMUNE LANDSCAPE OF OVARIAN CANCER: AN IN-DEPTH ANALYSIS OF IGCH CD4+, CD8+, AND PD-L1 IN TUMOR MICROENVIRONMENT AND THEIR THERAPEUTIC IMPLICATIONS

    Firdavs Ulmasov, Dilfuzakhon Mamarasulova, Bustonoy Esankulova

    МақолаImmune Cell Function and InteractionMedical science of Uzbekistan20250 иқтибос
    ABI

  7. The role of macrophages in cancer progression: M1, M2 subtypes, and their impact on tumor microenvironment

    Mamatova Irodakhon Yusupovna, Ibrohimjon Rahmonovich Asqarov, Gulruxan Jurayevna Ulug’bekova

    МақолаImmune cells in cancerInternational Journal of Innovative Research and Scientific Studies20250 иқтибос
    ABI

  8. Immuno-oncology approaches to overcome T cell exhaustion in melanoma

    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mohammad Y. Alshahrani, Muzdalifa Mejbel Fedwi +7

    МақолаCancer Immunotherapy and BiomarkersSeminars in Oncology20250 иқтибос
    ABI

  9. THE ROLE OF THE TUMOR MICROENVIRONMENT IN THE TREATMENT AND PROGNOSIS OF BREAST CANCER

    Rakhimova, Farangiz

    МақолаImmune cells in cancerZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
    ABI

  10. THE ROLE OF THE TUMOR MICROENVIRONMENT IN THE TREATMENT AND PROGNOSIS OF BREAST CANCER

    Rakhimova, Farangiz

    МақолаImmune cells in cancerZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
    ABI

  11. Correction: Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation

    Kulsoom, Wajahat Ali, Saleem Ahmad +8

    БошқаCancer Immunotherapy and BiomarkersMolecular Biology Reports20250 иқтибос
    ABI

  12. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

    Qianqian Huang, Fan Tong, Jiantao Chen +5

    Шарҳ мақолаNanoplatforms for cancer theranosticsAdvanced Science20250 иқтибос
    ABI

  13. Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

    Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10

    Шарҳ мақолаT-cell and B-cell ImmunologyImmunological Investigations20250 иқтибос
    ABI

  14. New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK

    Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad +7

    Шарҳ мақолаCAR-T cell therapy researchFunctional & Integrative Genomics20250 иқтибос
    ABI

  15. Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies

    Omer Qutaiba B. Allela, Ali Fawzi Al-Hussainy, Gaurav Sanghvi +9

    Шарҳ мақолаCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
    ABI

  16. SLAMF8 (BLAME) as a novel immune checkpoint: Implications for inflammation, autoimmunity, and oncology

    Ahmed Husseni, Farag M. A. Altalbawy, Irwanjot Kaur +7

    Шарҳ мақолаImmune Cell Function and InteractionPathology - Research and Practice20250 иқтибос
    ABI

  17. A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors

    Saade Abdalkareem Jasim, Jitendra Gupta, Subasini Uthirapathy +7

    Шарҳ мақолаCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
    ABI

  18. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

    Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

    МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос
    ABI

  19. THE MICROBIOME FACTOR IN ONCOLOGY: ENHANCING DRUG EFFICACY AND REDUCING ADVERSE EFFECTS THROUGH MICROBIOTECHNOLOGICAL MODULATION

    Najmiddin Xabibullayev, Hakim To'ychiyev

    МақолаGut microbiota and healthOpen MIND20260 иқтибос
    ABI

  20. THE MICROBIOME FACTOR IN ONCOLOGY: ENHANCING DRUG EFFICACY AND REDUCING ADVERSE EFFECTS THROUGH MICROBIOTECHNOLOGICAL MODULATION

    Najmiddin Xabibullayev, Hakim To'ychiyev

    МақолаGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  21. Nervous and immune system crosstalk shapes cancer progression and treatment response

    Mustafa TArdah, Raghda AliBakr, H. Malathi +6

    МақолаCancer, Stress, Anesthesia, and Immune ResponseDiscover Oncology20260 иқтибос
    ABI

  22. Integrating histopathology and immune marker analysis for machine learning-based colorectal cancer prognostics

    Mohamed J. Saadh, Tamara Nazar Saeed, Karar H. Alfarttoosi +10

    МақолаAI in cancer detectionDiagnostic Pathology20260 иқтибос
    ABI

  23. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

    Qamar Abuhassan, Ali M Atoom, M.M. Rekha +5

    МақолаPsoriasis: Treatment and PathogenesisHuman Immunology20260 иқтибос
    ABI

  24. Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity

    Chou-Yi Hsu, Ahmed Hjazi, Muath Suliman +7

    МақолаCancer Immunotherapy and BiomarkersJournal of Pharmacology and Experimental Therapeutics20260 иқтибос
    ABI

  25. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

    Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    МақолаCancer Immunotherapy and BiomarkersAnnals of Hematology20260 иқтибос
    ABI